October Chst9 Marks a Spatially and Transcriptionally Unique Population of Oprm1-Expressing Neurons in the Nucleus Accumbens Emma Andraka Robert A. Phillips III Kasey L. Brida Jeremy J. Day jjday@uab.edu 2023 17 2023

Summary: Opioids produce addictive, analgesic, and euphoric effects via actions at mu opioid receptors (µORs). The µOR is encoded by the Oprm1 gene and is expressed in multiple brain regions that regulate reward and motivation, such as the nucleus accumbens (NAc). Oprm1 expression in NAc medium spiny neurons (MSNs) mediates opioid place preference, seeking, and consumption. However, recent single nucleus RNA sequencing (snRNA-seq) studies in rodent, primate, and human NAc have revealed that multiple subpopulations of NAc neurons express Oprm1 mRNA, making it unclear which populations mediate diverse behaviors resulting from µOR activation. Using published snRNA-seq datasets from the rat NAc, we identified a novel population of MSNs that express the highest levels of Oprm1 of any NAc cell type. Here, we show that this population is selectively marked by expression of Chst9, a gene encoding a carbohydrate sulfotransferase. To validate this observation and characterize spatial localization of this population in the rat NAc, we performed multiplexed RNAscope fluorescence in situ hybridization studies to detect expression of Oprm1 and Chst9 mRNA along with well-validated markers of MSNs. Notably, Chst9+ neurons exhibited more abundant expression of Oprm1 as compared to other cell types, and formed discrete cellular clusters along the medial and ventral borders of the NAc shell subregion. Moreover, CHST9 mRNA was also found to mark specific MSN populations in published human and primate snRNA-seq studies, indicating that this unique population may be conserved across species. Together, these results identify a spatially and transcriptionally distinct NAc neuron population characterized by the expression of Chst9. The abundant expression of Oprm1 in this population and the conservation of these cells across species suggests that they may play a key functional role in opioid response and identify this subpopulation as a target for further investigation.

INTRODUCTION

Opioids induce rewarding and reinforcing properties by acting at endogenous opioid receptors in the central nervous system, and repeated experience with opioids can lead to physical dependence, substance use disorder, and overdose-related deaths. Endogenous and synthetic opioids activate a conserved family of Gai-coupled GPCRs that include the mu, delta, and kappa opioid receptors, which are encoded by Oprm1, Oprd1, and Oprk1, respectively. Commonly used opioid drugs such as morphine and fentanyl produce reward via actions primarily at the mu opioid receptor (µOR). For example, morphine conditioned place preference and dependence is lost in transgenic mice with constitutive deletion of the Oprm1 gene1, demonstrating that this receptor is required for opioid reward. Similarly, the µOR plays critical roles in motivation for natural rewards and social behaviors. Oprm1-/- mice do not increase palatable food consumption aeftr a period of deprivation 2, and both Oprm1-/- and Oprm1+/- mice have impaired social interactions3. However, developing a complete understanding of µOR contributions to behavior is dificult due to the broad expression of Oprm1 in many distinct brain nuclei and cell types4,5, each of which may contribute to distinct opioid actions.

A major target of investigation for the rewardrelated functions of opioids is the nucleus accumbens (NAc), a striatal subregion that integrates information about motivational states, hedonic stimuli, rewardpaired cues, and contextual information6–8. eTh NAc is divided into two subregions, the core and shell. ehT core envelops the anterior commissure and is architecturally and functionally similar to the dorsal striatum. eTh NAc shell represents the most medial and ventral aspect of the NAc. While the NAc core facilitates learning and reward-related associations, the NAc shell is primarily implicated in the rewarding and reinforcing qualities of relevant stimuli6,7,9. Ample evidence has also demonstrated that the NAc serves as a hub for the eefcts of opioids on motivated behavior5,6. Selective restoration of Oprm1 expression in a subset of striatal neurons in Oprm1-/- mice rescues morphine reward, without altering the analgesic properties or withdrawal eefcts of morphine 10. Likewise, direct infusions of µOR agonists into the NAc increase food consumption8,11, sucrose drinking12, and intake of high-fat foods13,14, whereas intra-NAc nuclei through projections to the ventral pallidum20–22. expression examining

subpopulations the

NAc, we first consulted a rat NAc34. This study identified 16 transcriptionally distinct cell populations, including principal MSNs that express Ppp1r1b (the gene encoding dopamineand cyclic

AMP-related

phosphoprotein-32, or DARPP-32; Fig. 1a-b) among other canonical MSN markers (Fig. 4d). MSN populations in the rat NAc included previously characterized D1-MSNs and D2MSNs, as well as a novel Ppp1r1b+ population termed visualize the spatial distribution of targeted gene transcripts. oThugh

Oprm1 and Grm8 expression can be observed across the broader NAc, Chst9 expression was restricted to a much smaller group of cells, again highlighting the selectivity of this marker across NAc subpopulations (Fig. 2c). Curiously, this Chst9+ population appears to form discrete cellular clusters along the medial and ventral borders of the NAc shell subregion (Fig. 2c). To confirm this observation across all animals, region of interest (ROI) coordinates from quantified cell types were combined into an integrated administration tasks16,18,19. µOR antagonists decrease sucrose intake and feeding behavior15. Additionally, opioid receptor antagonists delivered into the

NAc block opioid reinforcement and social reward16,17, and direct infusion of µOR receptor agonists into the NAc is reinforcing in selfhT

e principal cells of the NAc are GABAergic medium spiny neurons (MSNs) that directly target the output nuclei of the basal ganglia (ventral tegmental area and substantia nigra) or indirectly target these

MSNs are further separated by expression of the

Drd1 distinct and

Drd2 dopamine receptors, which form populations termed

D1-MSNs and D2-MSNs23,24. understanding striatal physiology25, circuitry26, and molecular responses to drugs of abuse27–29, both cell populations express Oprm130 and contribute to opioidinduced behaviors31. Further, recent single nucleus RNA sequencing (snRNA-seq) studies have revealed unexpected heterogeneity in MSNs within the NAc and broader striatum, with multiple subtypes of Drd1 and Drd2 expressing MSNs present in the mouse32, rat33–35, monkey36,37, and human NAc37,38. Strikingly, NAc MSN subtypes exhibit highly variable expression of Oprm134, highlighting the need for further investigation into the roles of distinct MSN subclasses in opioid action. Here, to we leveraged available snRNA-seq characterize a subpopulation of

NAc datasets

MSNs that exhibit the highest level of Oprm1 expression across all defined NAc cell types. Using data-driven comparisons, we identified a marker gene (Chst9, which encodes a carbohydrate sulfotransferase) that defines this neuronal population. Next, we employed single molecule RNA uflorescence in situ hybridization to validate this marker and map the spatial location of this transcriptionally defined cell type in the rat NAc. Finally, comparison of transcriptional profiles of MSN subtypes from the rat, monkey, and human NAc revealed that this cell population is conserved across species. Together, these findings highlight a unique population of NAc neurons with abundant Oprm1 expression and identify a specific molecular marker that may be useful in future targeting of this cell type.

RESULTS

Computational identification of a novel marker gene 2b-c).

Grm8-MSNs due to enrichment of the gene Grm8, the gene encoding the

metabotropic glutamate receptor 8 (Fig. 1c). Interestingly, Oprm1 mRNA was highly expressed within a large proportion of Grm8-MSNs (Fig. 1d). However, we also observed less abundant Grm8 and Oprm1 expression in a smaller fraction of D1 and D2-MSN subpopulations (Fig. 1c-d), meaning this subpopulation cannot be distinguished by the colocalization of these genes alone.

To further signatures investigate the

unique of these

Grm8-MSNs, gene we conducted a diefrential expression analysis using pseudobulked gene expression matrices across 8 biological replicates. Comparing the gene expression signature of the Grm8-MSN cluster to all other cell clusters identified 223 genes enriched in the Grm8MSN cluster and 859 genes significantly depleted in this population. Among enriched genes, Chst9 (encoding carbohydrate sulfotransferase 9) was the most highly enriched diefrentially expressed gene in the Grm8MSN population (Fig. 1e). We then assessed whether Chst9 is selective for the Grm8-MSN cluster using the Gini coeficient, a

metric useful for identifying variables not equally shared across groups or clusters of cells. This analysis identified

Chst9 as a potential

marker gene for the

Grm8-MSN population, as it exhibits selectively high expression for that population only (Fig. 1f). eTh evaluation of

Chst9 expression within all other NAc cell populations, utilizing the same analysis pathway, confirmed this observation— every cluster outside of Grm8-MSNs lacked

Chst9 expression, identifying this as a unique marker gene (Fig. 1g).

Validation of Chst9 as an Oprm1+ subpopulation marker gene

To validate snRNA-seq findings demonstrating that Chst9 is in a distinct population

of Grm8+/ Oprm1+ MSNs in the NAc, we employed RNAscope39, a

widely ulforescence implemented single molecule

RNA in situ

hybridization (smRNA-FISH) platform for multiplexed transcript detection. Tissue sections containing the NAc from naïve rats were used for multiplexed hybridization using distinct probes for Grm8, Oprm1, and Chst9 (Fig. 2a-c). Consistent with rat NAc snRNA-seq data, Grm8, Oprm1, and Chst9 mRNA colocalized in a subset of NAc neurons (Fig.

Chat-Int.

Sst-Int.

GABAergic

Drd1 MSN-2

NAc snRNA-seq Astrocyte Polydendrocyte

Pvalb-Int.

Microglia Grm8-MSN

Mural DMrSd3N- GlutamatOerlgigic-1

Drd1-MSN-1 spatial map, forming a spatially co-registered map of cell type location of the NAc (Fig. 2d). eThse maps further revealed that although Oprm1+ cells are distributed across the medial/lateral and dorsal/ventral axes of the NAc, Chst9+ cells were relatively confined along the NAc shell’s medial and lateral border (Fig. 2d). Additionally, by reflecting the degree of Oprm1 expression in the area of each point, this map suggested that nearly all Chst9+ cells also abundantly expressed Oprm1 (Fig. 2d).

To confirm the relative expression of Oprm1 within diefrent NAc cell types, we quantified the intensity and transcript-level puncta of Oprm1 signal within all Oprm1+ cells. Oprm1+ cells were then further identified as Chst9+ or Chst9-. eThse analyses verified significantly elevated expression of Oprm1 in Chst9+ cells as compared to Chst9- cells (Fig. 2e). We additionally evaluated the percentage of diefrent NAc cell types, including Drd1+ and Ppp1r1b+ neurons, that express Oprm1. Oprm1 was detected in in ~40% of Drd1+ neurons, and in ~30% of total NAc cells (Fig. 2f). However, Oprm1 is expressed in over 90% of Chst9+ NAc neurons (Fig. 2f). In combination with snRNA-seq data, these observations confirm Chst9 as a selective marker for NAc neurons that abundantly express Oprm1 mRNA.

Conservation of Chst9+ neurons across mammalian species

While these studies identify Chst9+ MSNs in Grm8 Oprm1 Chst9 DAPI

b M

L D V

Grm8 Oprm1 Chst9 DAPI d 30 a t cn10 u p 1 m r p O 3 1

All Oprm1+ NAc core

AC

NAc shell *

* a

AC NAc shell Pdyn Drd2 Penk Adora2a Grm8 Oprm1 Chst9 Foxp2 D1−SDh2e−lS/ODheT1l−/NOUTDD1AD/DP12−−ICHDjy1b−rDMDid21a−−trMSiDxta2rti−oriSsxotrmioesome

D1-NUDAP .D1N_.DS1.D .D .D .D1.DF _.DA2_.D2N.D

A _B1_C1_D1_E _ 2 B _C2_D

NSNSNSNSNSNSNS MSNMSM M M M M M M M

MSN.D1_F DRD1 EBF1 PDYN DRD2 PENK ADORA2A GRM8 OPRM1 CHST9 FOXP2 PPP1R1B

PPP1R1B FOXP2 BCL11B GAD1 DRD1 PDYN EBF1 HTR4 DRD2 ADORA2A PENK GRM8 OPRM1 CHST9 c f llvee 4 n o iss0.6 e r p xE 4 2 3 2 3 4 3 5 3

DRD1 EBF1 PDYN DRD2 PENK ADORA2A GRM8 OPRM1 CHST9 FOXP2 PPP1R1B

PPP1R1B FOXP2 BCL11B GAD1 DRD1 PDYN EBF1 HTR4 DRD2 ADORA2A PENK GRM8 OPRM1 CHST9

Rat MSNs Phillips, et al., 2023 (Mol. Cell. Neurosci.)

NHP MSNs He, et al., 2021 (Current Biology)

Human MSNs Tran, et al., 2021

(Neuron) 11BPPR 2FPXO 11LBBC 1ADG 1RDD PYND 1FEB 4THR 2RDD 2AARO EKPN 8RGM 1PROM 9TSHC P AD coexp%reosfscinegllttwypoegenes 11BPPR 2FPXO 11LBBC 1ADG 1RDD PYND 1FEB 4THR 2RDD 2AARO EKPN 8RGM 1PROM 9TSHC

P AD 0 20 40 60 80 100 Figure 3. Identification of conserved populations of Chst9+ MSNs in non-human primates and humans. a-c, Violin plots of MSN marker genes in transcriptionally defined cell populations of the rat (a), non-human primate (b), and human (c) NAc. d-f, Coexpression heatmaps showing the percent of cells within the rat Grm8-MSN cluster (d), non-human primate D1-NUDAP cluster (e), or human MSN.D1_F cluster (f) coexpressing identified genes. the rat brain, we next investigated conservation of expression of other marker genes as well. To examine this NAc cell population across species, with a focus whether this was the case, we generated co-expression on higher-order mammals. To do this, we leveraged heatmaps of selected transcripts within Grm8publicly available snRNA-seq atlases of the non- MSNs, D1-NUDAP cells, and MSN.D1_F cells (Fig. human primate (NHP)36 and human38 NAc that have 3d-f). For this analysis, we prioritized previously previously been used to compare gene expression characterized markers of MSNs or MSN subtypes, profiles and MSN subtypes across species 34. As in addition to Grm8, Chst9, and Oprm1. Consistent previously described, both NHP and human datasets with a potentially conserved role across rodent and identified unique MSN clusters that exhibit similar primate NAc samples, we observed similar patterns marker gene expression patterns to those observed in of expression for additional marker genes in these the rat NAc (Fig. 3a-c). eTh direct comparison of Grm8, populations. For example, each cluster included a Oprm1, and Chst9 expression between these species high percentage of cells expressing the genes Foxp2 revealed that one cell type in each respective dataset and Bcl11b, commonly cited markers of MSNs40,41. exhibited colocalization and abundant expression Furthermore, an appreciable subset of cells in each of both Grm8/GRM8 and Oprm1/OPRM1. Notably, cluster expressed Drd1/DRD1 and Pdyn/PDYN, both the same population was marked by cluster-selective established markers of D1-MSNs42,43. Additionally, Chst9/CHST9 expression. While the rat literature had feature expression plots from each species confirmed termed these populations Grm8-MSNs, NHP datasets a similar expression of Drd1/DRD1, among other termed them D1-NUDAP cells, and human datasets genes, across these three clusters (Fig. S1). Taken referred to these as MSN.D1_F cells (Fig. 3a-c). together, this finding demonstrates that Grm8-MSNs,

Transcriptionally conserved cell types should and specifically Chst9+ neurons, are conserved across be expected to display a similar enrichment and co- species and exhibit similar gene expression signatures

Notably, this cell population exhibits the highest to µOR activation. Prior evidence from Fos plume

investigation into the circuit and behavioral role of single or repeated cocaine administration34. Future hT

e anatomical localization of Chst9+ MSNs at electrophysiological and transcriptional responses of to previously described cell types in higher-order mammals.

DISCUSSION

Recent large-scale single cell sequencing platforms have enabled comprehensive dissection of the molecular architecture of the striatum (including the NAc) in multiple species32–36,38. While these eofrts have identified transcriptionally distinct subdivisions within larger D1-MSN and D2-MSN subclasses, the convergence of cell types and the reliability of specific marker genes across species remains unclear. Here, we leveraged published snRNA-seq datasets from the rat NAc to identify putative transcriptional markers of Grm8-MSNs, a poorly characterized population of neurons that has been identified in multiple rodent snRNA-seq datasets across diefrent laboratories 33–35,44. expression of Oprm1 within the NAc, and is selectively marked by mRNA for the carbohydrate sulfotransferase gene

Chst9. At an anatomical level, Chst9+ MSNs populate the ventral and medial borders of the NAc shell subregion, where they localize in discrete clusters that co-express Grm8. Moreover, we demonstrate that Chst9+ cells are observed in NAc subpopulations in the monkey and human NAc, providing evidence for a conserved transcriptional profile. Together, these results help to define a poorly characterized cell type in the NAc, and highlight the need for further Chst9+ MSNs. the border of the rat NAc may generate confusion given the proximity to other nearby landmarks, including the Islands of Calleja and anterior components of the ventral pallidum that perforate the ventral NAc shell. Fortunately, these distinct nuclei can be reliably distinguished from principal NAc neurons at the molecular level. For example, the Islands of Calleja are densely organized pockets of granule cells within the ventral striatum, which play a key role in grooming behavior45. While the Islands of Calleja can easily be localized in a coronal section based on cell density alone (e.g., increased DAPI+ territories in Fig. 2a), they are also marked by robust expression of the Drd3 receptor45, which is largely absent in Chst9+ MSNs.

Likewise, Chst9+ MSNs do not express other markers of ventral pallidum

neuronal subtypes, including Npas1 and Pvalb46,47, but do express appreciable levels of D1-MSN

markers including Drd1, Bcl11b, Pdyn, and Ppp1r1b. Together with molecular conservation in higher-order

mammals, these results argue that Chst9+ MSNs represent a distinct cell type that is both transcriptionally and anatomically separate from other defined MSN subtypes 34,36.

Strong evidence supports a critical role of µORs in the NAc in the rewarding and reinforcing properties of opioids. However, the specific contributions of distinct cell types or anatomical subregions is only beginning to be understood. Landmark studies previously identified “hotspots” for opioid eefcts on hedonic reactions to sucrose reward, as defined by enhancement

of orofacial aefctive taste reactivity measures8,11,48,49. eThse studies outlined a rostrodorsal domain of the medial NAc shell as having the most robust eefcts in stimulating “liking” of palatable rewards, whereas µOR activation in other regions of the NAc produced more moderate eefcts or even generated food avoidance.

Notably, the strongest hedonic eefcts of µOR activation at least partially overlap

with the distribution of Chst9+ clusters in the NAc shell (Fig. 2d), suggesting a possible role for these cells in hedonic reactions to palatable foods. Given the abundant expression of Oprm1 in Chst9+ cells and the high fraction of Chst9+ cells that express Oprm1, it would be a reasonable assumption that these cells would be among the most responsive mapping following direct NAc microinfusions of µOR agonists identified dose-dependent elevations in FOS protein11,14,49, but the molecular identity of FOS+ cells was not investigated. Similarly, an early single cell RNA-seq investigation revealed increased activitydriven gene expression in a small subset of D1-MSNs aeftr morphine exposure in a mouse model 50, although it is unclear if these changes were confined to a distinct subset of D1-MSNs. Likewise, a recent study found no change in Fos (or related

AP-1 transcription factor

family member Fosb) in Grm8-MSNs following either studies will be needed to comprehensively define the Chst9+ cells to opioids and other psychoactive drugs.

Although we identified

Chst9 as the most specific marker for Grm8-MSNs, we also detected elevated levels of other potential marker genes in this population (Fig. 1e). eThse included zinc finger homeobox 1) and

Tac3

Tshz1 (Teashirt (Tachykinin precursor 3; the rat ortholog of mouse Tac2). Each of these genes have recently been discovered by other groups to mark specific populations of MSNs in the dorsal and ventral striatum, and cells expressing these genes have been shown to be important for aversive aspects of motivated behavior43,51. Tshz1 is expressed by a subgroup of striosomal D1-MSNs located in the dorsal striatum, but is also found in the ventral striatum.

Notably,

Tshz1+ neurons in the dorsal striatum are activated by aversive stimuli, and optogenetic stimulation of these cells causes place aversive and suppresses locomotion43. Similarly, inhibiting Tshz1+ MSNs impairs learning related to punishment, but does not impact reward learning. However, while this study characterized Tshz1+

MSNs in the dorsal striatum,

nothing is known about the behavioral role of Tshz1+ neurons in the ventral striatum or NAc, and we did not observe significant Chst9 expression in the dorsal striatum. Similarly, another recent study identified Tac2 mRNA to mark a subpopulation of D1-MSNs in the mouse NAc51. This study found that acute cocaine decreased activity of Tac2+ neurons, and stimulation of this population suppressed cocaine place preference brains were then wrapped in aluminum foil and placed and self-administration. Given the enrichment of Tac3 on dry ice. Tissue was stored at -80°C until the day of in rat Grm8-MSNs, the cells targeted in this mouse sectioning. Aeftr a 30-minute equilibration at -20°C, study likely overlap to some extent with the Chst9+ 10 μm coronal sections were obtained using a Leica cells investigated in the present manuscript. However, CM 1850 cryostat (Deer Park, IL, USA) set to -20°C. further work is needed to characterize the circuit and Sections containing the NAc, ranging from 1.68behavioral role of this population, including synaptic 1.92 mm anterior-posterior (A/P) to Bregma, were inputs and downstream targets. mounted onto room temperature frosted microscope

In summary, we have identified a slides, air dried for 60 minutes at -20°C, and stored at transcriptionally and anatomically unique population -80°C until staining. of NAc MSNs marked by high expression of Oprm1 and selective expression of Chst9. Given that this population Tissue preparation and imaging for RNAscope. eTh expresses other markers of D1-MSNs, it is likely that RNAscope Multiplex Fluorescent v2 assay kit (ACD prior labeling studies or genetic manipulations may Bio, 323110) and RNAscope 4-plex ancillary kit (ACD have targeted this cell population along with more Bio, 323120) were used to stain sections, following the classically defined D1-MSNs that do not express Chst9 manufacturer’s recommended protocol. Probe sets and exhibit lower expression of Oprm1. For example, used include DAPI (320858), Rn-Oprm1-C1 mRNA use of Drd1 or prodynorphin (Pdyn) gene promoter (410691-C1), Rn-Grm8-C2 mRNA (1149671-C2), sequences is a common strategy for cell-restricted Rn-Chst9-C4 mRNA (1149681-C4), Rn-Ppp1r1b-C2 expression of transgenes in D1-MSNs2,21,52–54. Using this mRNA (1048941-C2), and Rn-Drd1-C3 mRNA strategy, prior work has revealed that Oprm1 expression (317031-C3). Three diefrent groups of sections were in Pdyn+ cells (using a Pdyn BAC transgenic mouse) probed, with varying marker probe combinations— is suficient to restore opioid reward in an Oprm1-/- group 1 (Chst9 population validation experiment) mouse10. However, based on the present results (as well probes included Oprm1, Grm8, and Chst9; group as recent work demonstrating that Pdyn regulatory 2 (MSN marker experiment) probes included elements are accessible in Grm8-MSNs55), it is likely Oprm1, Ppp1r1b, and Drd1; group 3 (MSN marker that this manipulation restores Oprm1 expression in experiment) probes included Oprm1, Ppp1r1b, and multiple MSN subtypes including Chst9+ cells, which Chst9. Channels were matched with genes according may each contribute to opioid reward in distinct ways. to relative expression level and channel background Our results highlight the previously underappreciated in diefrent experiments: the green channel (520 nm diversity within broad striatal MSN subclasses, and dye, recommended for high expressors) was assigned underline the need for continued exploration of the to Grm8, Ppp1r1b, and Oprm1, the red channel distinct roles of unique cell types. (570 nm dye, recommended for low expressors) was assigned to Oprm1, and the white channel (690 nm METHODS dye, recommended for low expressors) was assigned to Chst9 and Drd1. 5 total sections (1 each from 3M/2F) were used for the Chst9 population validation experiment, and 6 total sections (1 each from 3M/3F) were used for each of the MSN marker experiment.

Aeftr staining, sections were imaged using the BZX800 Keyence Microscope, and then stitched using the BZ-X800 Keyence Analyzer software. High sensitivity images were taken using OP-87767 filter cubes for GFP (Channel 1, green), Texas Red (PE) (Channel 2, red), DAPI (Channel 3, blue) and Cy5 (Channel 4, white) at 4x (PlanApo NA 0.20), 20x (Plan Fluor NA 0.45 Ph1), and 100x (PlanApo 1.45/0.113 mm Oil) magnifications.

Animals. Adult male and female Sprague-Dawley rats were obtained from Charles River Laboratories (Wilmington, MA, USA). Rats were cohoused in pairs in plastic filtered cages with nesting enrichment in an Association for Assessment and Accreditation of Laboratory Animal Care–approved animal care facility maintained between 22° and 24°C on a 12hour light/12-hour dark cycle with ad libitum food (Lab Diet Irradiated rat chow) and water. Bedding and enrichment were changed weekly by animal resources program staf. A total of 6 naïve rats (n = 3M/3F) were used in initial Chst9 population and MSN characterization experiments. Animals were randomly assigned to experimental groups. All experiments were approved by the University of Alabama at Birmingham Institutional Animal Care and Use Committee (IACUC).

Brain tissue collection. Rats were euthanized by live decapitation using a guillotine (World Precision Instruments, Sarasota, FL, USA). Brains were rapidly removed and submerged in 2-methylbutane, chilled on dry ice, for approximately 30 seconds. Flash-frozen Image analysis. Approximate A/P coordinates of sections were determined by comparing anatomical landmarks within 4x whole section images to those in coordinate and region-labeled diagrams of the Paxinos and Watson rat brain atlas56. eThse A/P distinctions were used to process 20x ROI images of the NAc. This protocol was used for the Chst9 population validation and MSN marker experiments.

To isolate the NAc for quantification, brain atlas templates at the corresponding A/P coordinate to that of a given section were overlaid on 20x images of

Statistical analysis. All image data were analyzed statistically with Prism software using the nested t-test (Chst9 population validation experiment) or Welch’s t-test (fentanyl experiment). A 95% confidence level was set for every test, with a definition of statistical significance at p < 0.05. All graphs, diagrams, and image edits were made using Prism, Adobe Illustrator, R Studio, and FIJI.

Published snRNA-seq data analysis. Data objects for NHP and human NAc snRNA-seq datasets were obtained from data repositories outlined in each respective publication. eTh data object for the rat NAc snRNA-seq dataset was provided directly by Robert Phillips at the University of Alabama at Birmingham (UAB). All data objects were analyzed with R software. that section in Adobe Illustrator (San Jose, CA, USA) using anatomical landmarks as a guide. This overlay image was then imported into FIJI57 to create NAcspecific ROIs for that 20x image. eThse ROIs were then applied to each individual channel of the original 20x image, and the NAc was cropped from the rest of each channel’s image using the Clear Outside plugin. DAPI channel nuclei-specific ROIs were generated with the StarDist-2D plugin58, using the “Versatile (uflorescent nuclei)” model with a probability/score threshold of 0.20 and an overlap threshold of 0.45. Nuclei-specific ROIs were then applied to images containing Oprm1, Grm8, Chst9, Ppp1r1b, or Drd1 probe signal, and raw signal intensity within each ROI was measured.

Cell types were categorized based on positive marker colocalization within a single ROI, and intensity values were determined within diefrent cell types, using R Studio. Nuclei-specific ROI positions were used to plot locations of diefrent cell types, using R Studio.

100x magnification images were taken using the z-stack setting. One image for each channel within a stack was chosen for analysis, for a total of 10-14 images per animal within the Chst9 population validation experiment. Selected channel images for one total z-stack image were merged, and the resulting overlay was converted to Nikon (.nd2) format using NIS-Elements software. Nuclei-specific ROIs were generated around DAPI staining using QuPath59 software version 0.3.2. Cell detection parameters were set to background radius 0 px, median filter radius CONFLICTS OF INTEREST 0 px, minimum area 100 px^2, maximum area 3000 ehT authors declare no competing interests. px^2, threshold 35, and cell expansion 3 px. For cell detection, “split by shape”, “include cell nucleus”, “smooth boundaries”, and “make measurements” boxes were checked. Marker puncta-specific ROIs were then generated, and counts were measured within each DAPI ROI for an image. Subcellular detection parameters were set to expected spot size 12 px^2, minimum spot size 0.5 px^2, and maximum spot size 25 px^2. Cell types were categorized based on positive marker colocalization within a single ROI, and puncta counts were determined within diefrent cell types, using R Studio.

ACKNOWLEDGEMENTS

We thank all current and former Day Lab members for assistance and support. This work was supported by NIH grants DP1DA039650, R01MH114990, R01DA053743, R01DA054714, and the  McKnight Foundation  Neurobiology of Brain Disorders Award (JJD). R.A.P.III is supported by the AMC21 scholar program and the UAB T32 in the Neurobiology of Cognition and Cognitive Disorders (T32NS061788).

AUTHOR CONTRIBUTIONS

E.A. and J.J.D. conceived of experiments. E.A. performed all experiments. E.A. and J.J.D. harvested brains for the marker validation experiment. E.A. analyzed smRNA-FISH data with assistance from R.A.P.III and K.L.B. R.A.P.III analyzed published snRNA-seq data. All authors have approved the final version of the manuscript.

Data for Grm8, Oprm1, Chst9, Ppp1r1b, and Drd1 expression were obtained in the form of UMAP cluster plots and violin plots through Seurat60, ggplot2, and dplyr package processing in R Studio.

DATA AVAILABILITY

All relevant data that support the findings of this study are available by request from the corresponding author (J.J.D.). 37. Phan, B. N. et al. Single nucleus transcriptomics chromosomes. Nature 425, 917–925 (2003). of human and monkey striatum implicates 53. Shuen, J. A., Chen, M., Gloss, B. & Calakos, DNA damage, neuroinflammation, and N. Drd1a-tdTomato BAC transgenic mice for neurodegenerationsignalinginopioidusedisorder. simultaneous visualization of medium spiny BioRxiv (2023). doi:10.1101/2023.05.17.541145 neurons in the direct and indirect pathways of the 38. Tran, M. N. et al. Single-nucleus transcriptome basal ganglia. J. Neurosci. 28, 2681–2685 (2008). analysis reveals cell-type-specific molecular 54. Pettibone, J. R. et al. Knock-In Rat Lines with Cre signatures across reward circuitry in the human Recombinase at the Dopamine D1 and Adenosine brain. Neuron 109, 3088–3103.e5 (2021). 2a Receptor Loci. eNeuro 6, (2019 ). 39. Wang, F. et al. RNAscope: a novel in situ RNA 55. Phillips, R. A. et al. Temporally specific gene analysis platform for formalin-fixed, parafin- expression and chromatin remodeling programs embedded tissues. J Mol Diagn 14, 22–29 (2012). regulate a conserved Pdyn enhancer. BioRxiv 40. Arlotta, P., Molyneaux, B. J., Jabaudon, D., (2023). doi:10.1101/2023.06.02.543489 Yoshida, Y. & Macklis, J. D. Ctip2 controls the 56. Paxinos, G. & Watson, C. eTh Rat Brain in diefrentiation of medium spiny neurons and the Stereotaxic Coordinates. 472 (Academic Press, establishment of the cellular architecture of the 2013).

striatum. J. Neurosci. 28, 622–632 (2008). 57. Schindelin, J. et al. Fiji: an open-source platform 41. Cirnaru, M.-D. et al. Unbiased identification for biological-image analysis. Nat. Methods 9, of novel transcription factors in striatal 676–682 (2012). compartmentation and striosome maturation. 58. Schmidt, U., Weigert, M., Broaddus, C. & Elife 10, (2021). Myers, G. in Medical Image Computing and 42. Gerfen, C. R. et al. D1 and D2 dopamine receptor- Computer Assisted Intervention – MICCAI 2018: regulated gene expression of striatonigral and 21st International Conference, Granada, Spain, striatopallidal neurons. Science 250, 1429–1432 September 16-20, 2018, Proceedings, Part II (eds. (1990). Frangi, A. F., Schnabel, J. A., Davatzikos, C., 43. Xiao, X. et al. A genetically defined Alberola-López, C. & Fichtinger, G.) 11071, 265– compartmentalized striatal direct pathway for 273 (Springer International Publishing, 2018). negative reinforcement. Cell 183, 211–227.e20 59. Bankhead, P. et al. QuPath: Open source software (2020). for digital pathology image analysis. Sci. Rep. 7, 44. Hughes, B. W. et al. NPAS4 supports drug-cue 16878 (2017).

associations and relapse-like behavior through 60. Butler, A., Hofman, P., Smibert, P., Papalexi, E. regulation of the cell type-specific activation & Satija, R. Integrating single-cell transcriptomic balance in the nucleus accumbens. BioRxiv (2022). data across diefrent conditions, technologies, and doi:10.1101/2022.09.04.506434 species. Nat. Biotechnol. 36, 411–420 (2018). 45. Zhang, Y.-F. et al. Ventral striatal islands of Calleja neurons control grooming in mice. Nat. Neurosci.

24, 1699–1710 (2021). 46. Morais-Silva, G. et al. Molecular, circuit, and stress response characterization of Ventral Pallidum Npas1-neurons. J. Neurosci. (2022). doi:10.1523/

JNEUROSCI.0971-22.2022 47. Cui, Q. et al. Dissociable roles of pallidal neuron subtypes in regulating motor patterns. J. Neurosci.

(2021). doi:10.1523/JNEUROSCI.2210-20.2021 48. Castro, D. C. & Berridge, K. C. Opioid hedonic hotspot in nucleus accumbens shell: mu, delta, and kappa maps for enhancement of sweetness “liking” and “wanting”. J. Neurosci. 34, 4239–4250 (2014). 49. Peciña, S., Smith, K. S. & Berridge, K. C. Hedonic hot spots in the brain. Neuroscientist 12, 500–511 (2006). 50. Avey, D. et al. Single-Cell RNA-Seq Uncovers a

Robust Transcriptional Response to Morphine by

Glia. Cell Rep. 24, 3619–3629.e4 (2018). 51. Zhao, Z.-D. et al. A molecularly defined D1 medium spiny neuron subtype negatively regulates cocaine addiction. Sci. Adv. 8, eabn3552 (2022). 52. Gong, S. et al. A gene expression atlas of the

central nervous system based on bacterial artificial

1. Matthes , H. W. et al. Loss of morphine-induced analgesia, reward eefct and withdrawal symptoms in mice lacking the mu-opioid-receptor gene . Nature 383 , 819 - 823 ( 1996 ). 2. Castro , D. C. et al. An endogenous opioid circuit determines state-dependent reward consumption . Nature 598 , 646 - 651 ( 2021 ). 3. Toddes , C. , Lefevre , E. M. , Brandner , D. D. , Zugschwert , L. & Rothwell , P. E. μ-Opioid Receptor (Oprm1) Copy Number Inuflences Nucleus Accumbens Microcircuitry and Reciprocal Social Behaviors . J. Neurosci . 41 , 7965 - 7977 ( 2021 ). 4. Erbs , E. et al. A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks . Brain Struct. Funct . 220 , 677 - 702 ( 2015 ). 5. Le Merrer , J. , Becker , J. A. J. , Befort , K. & Kieefr , B. L. Reward processing by the opioid system in the brain . Physiol. Rev . 89 , 1379 - 1412 ( 2009 ). 6. Castro , D. C. & Bruchas , M. R. A Motivational and Neuropeptidergic Hub: Anatomical and Functional Diversity within the Nucleus Accumbens Shell . Neuron 102 , 529 - 552 ( 2019 ). 7. Day , J. J. & Carelli , R. M. eTh nucleus accumbens and Pavlovian reward learning . Neuroscientist 13 , 148 - 159 ( 2007 ). 8. Peciña , S. & Berridge , K. C. Hedonic hot spot in 8 nucleus accumbens shell: where do mu-opioids Nucleus Accumbens . Cell Rep . 28 , 2256 - 2263 . e3 cause increased hedonic impact of sweetness? J. ( 2019 ). Neurosci. 25 , 11777 - 11786 ( 2005 ). 23 . Le Moine , C. & Bloch , B. D1 and D2 dopamine 9. Loriaux , A. L. , Roitman , J. D. & Roitman , M. F. receptor gene expression in the rat striatum: Nucleus accumbens shell, but not core, tracks sensitive cRNA probes demonstrate prominent motivational value of salt . J. Neurophysiol. 106, segregation of D1 and D2 mRNAs in distinct 1537-1544 ( 2011 ). neuronal populations of the dorsal and ventral 10. Cui , Y. et al. Targeted expression of μ-opioid striatum . J. Comp. Neurol . 355 , 418 - 426 ( 1995 ). receptors in a subset of striatal direct-pathway 24 . Gerfen , C. R. Segregation of D1 and D2 dopamine neurons restores opiate reward . Nat. Neurosci . 17 , receptors in the striatal direct and indirect 254- 261 ( 2014 ). pathways: An historical perspective . Front. 11. Peciña , S. & Berridge , K. C. Opioid site in nucleus Synaptic Neurosci . 14 , 1002960 ( 2022 ). accumbens shell mediates eating and hedonic 25 . Shen , W. , Flajolet , M. , Greengard , P. & Surmeier , “ liking” for food: map based on microinjection D. J. Dichotomous dopaminergic control of Fos plumes . Brain Res . 863 , 71 - 86 ( 2000 ). striatal synaptic plasticity . Science 321 , 848 - 851 12. Zhang , M. & Kelley , A. E. Opiate agonists ( 2008 ). microinjected into the nucleus accumbens enhance 26 . Park , J. , Coddington , L. T. & Dudman , J. T. Basal sucrose drinking in rats. Psychopharmacology ganglia circuits for action specification . Annu . 132 , 350 - 360 ( 1997 ). Rev. Neurosci . 43 , 485 - 507 ( 2020 ). 13. Zhang , M. , Gosnell , B. A. & Kelley , A. E. Intake 27 . Calipari , E. S. et al. In vivo imaging identifies of high-fat food is selectively enhanced by mu temporal signature of D1 and D2 medium spiny opioid receptor stimulation within the nucleus neurons in cocaine reward . Proc. Natl. Acad. Sci. accumbens. J. Pharmacol. Exp. eThr. 285 , 908 - 914 USA 113, 2726 - 2731 ( 2016 ). ( 1998 ). 28 . Thi beault, K. C., Kutlu , M. G. , Sanders , C. & 14. Zhang , M. & Kelley , A. E. Enhanced intake of high- Calipari , E. S. Cell-type and projection-specific fat food following striatal mu-opioid stimulation: dopaminergic encoding of aversive stimuli in microinjection mapping and fos expression . addiction. Brain Res . 1713 , 1 - 15 ( 2019 ). Neuroscience 99 , 267 - 277 ( 2000 ). 29 . Bertran-Gonzalez , J. et al. Opposing patterns 15. Kelley , A. E. , Bless , E. P. & Swanson , C. J. of signaling activation in dopamine D1 and D2 Investigation of the eefcts of opiate antagonists receptor-expressing striatal neurons in response infused into the nucleus accumbens on feeding to cocaine and haloperidol . J. Neurosci . 28 , 5671 - and sucrose drinking in rats . J. Pharmacol. Exp . 5685 ( 2008 ). ehTr . 278 , 1499 - 1507 ( 1996 ). 30 . Oude Ophuis , R. J. A. , Boender , A. J., van Rozen, 16. van Ree, J. M. , Gerrits , M. A. & Vanderschuren , A. J. & Adan , R. A. H. Cannabinoid , melanocortin L. J. Opioids, reward and addiction: An encounter and opioid receptor expression on DRD1 and of biology, psychology, and medicine . Pharmacol . DRD2 subpopulations in rat striatum . Front. Rev . 51 , 341 - 396 ( 1999 ). Neuroanat. 8 , 14 ( 2014 ). 17. Trezza , V. , Damsteegt , R. , Achterberg , E. J. M. & 31 . Severino , A. L. et al. μ-Opioid Receptors on Vanderschuren, L. J. M. J. Nucleus accumbens Distinct Neuronal Populations Mediate Diefrent μ-opioid receptors mediate social reward . J. Aspects of Opioid Reward-Related Behaviors. Neurosci . 31 , 6362 - 6370 ( 2011 ). eNeuro 7 , ( 2020 ). 18. David , V. & Cazala , P. Anatomical and 32. Chen , R. et al. Decoding molecular and cellular pharmacological specificity of the rewarding eefct heterogeneity of mouse nucleus accumbens. Nat. elicited by microinjections of morphine into the Neurosci . 24 , 1757 - 1771 ( 2021 ). nucleus accumbens of mice . Psychopharmacology 33 . Savell , K. E. et al. A dopamine-induced gene 150 , 24 - 34 ( 2000 ). expression signature regulates neuronal function 19. Olds , M. E. Reinforcing eefcts of morphine in and cocaine response . Sci. Adv . 6, eaba4221 the nucleus accumbens . Brain Res . 237 , 429 - 440 ( 2020 ). ( 1982 ). 34 . Phillips , R. A. et al. Distinct subpopulations 20. Pardo-Garcia , T. R. et al. Ventral pallidum is the of D1 medium spiny neurons exhibit unique primary target for accumbens D1 projections transcriptional responsiveness to cocaine. Mol. driving cocaine seeking . J. Neurosci. 39 , 2041 - Cell . Neurosci. 125 , 103849 ( 2023 ). 2051 ( 2019 ). 35 . Reiner , B. C. et al. Single nucleus transcriptomic 21. Kupchik , Y. M. et al. Coding the direct/indirect analysis of rat nucleus accumbens reveals cell typepathways by D1 and D2 receptors is not valid for specific patterns of gene expression associated with accumbens projections . Nat. Neurosci . 18 , 1230 - volitional morphine intake. Transl. Psychiatry 12 , 1232 ( 2015 ). 374 ( 2022 ). 22. Baimel , C. , McGarry , L. M. & Carter , A. G. eTh 36 . He , J. et al. Transcriptional and anatomical Projection Targets of Medium Spiny Neurons diversity of medium spiny neurons in the primate Govern Cocaine-Evoked Synaptic Plasticity in the striatum . Curr. Biol . 31 , 5473 - 5486 . e6 ( 2021 ).